Compare Fiverr International Ltd (FVRR) vs Vertex Pharmaceuticals Incorporated (VRTX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Fiverr International Ltd vs Vertex Pharmaceuticals Incorporated — how do they compare? Fiverr International Ltd trades at $8.98 (market cap $326.79M), while Vertex Pharmaceuticals Incorporated trades at $529 (market cap $132.79B). The key difference: Vertex Pharmaceuticals Incorporated is far larger — about 406.3× Fiverr International Ltd's market cap, and Vertex Pharmaceuticals Incorporated is trading nearer its 52-week high, Fiverr International Ltd nearer its low. Which is the better fit depends on your goals.
| FVRR | VRTX | |
|---|---|---|
Market Cap | $326.79M | $132.79B |
Sector | Industrials | Health |
52-Week High | $26.67 | $529.65 |
52-Week Low | $8.75 | $376.62 |
Enterprise Value | $79.18M | $126.92B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Fiverr International (FVRR) trades at $9.42, up 2.39% on the day, but remains near its 52-week low amid bearish technical signals. The stock shows weak earnings momentum with Q2 2026 misses and lowered 2026 guidance due to AI disruption compressing demand for freelance services. Valuation ratios appear attractive with P/E of 11.63 and P/S of 0.83, while profitability metrics show modest improvement with net income margin at 7.18% for 2025.
The outlook is cautious with significant headwinds from AI adoption threatening Fiverr's core business model. Near-term risks include declining active buyers and revenue pressure, though current valuations may offer contrarian appeal if the company successfully adapts to AI challenges. Wall Street sentiment is neutral with 76% hold ratings and a $10.70 consensus price target suggesting limited upside.
Vertex Pharmaceuticals (VRTX) trades at $496.07, up 2.49% on the day, with a bullish technical signal from moving averages and strong institutional support. The company reported Q2 2026 revenue of $3.3 billion, beating estimates, and raised its full-year sales outlook, driven by cystic fibrosis treatments and newer products like CASGEVY. Financials show robust profitability with a 35% net income margin and positive cash flow trends, though recent EPS results have been mixed.
Outlook remains positive with an 84% analyst buy rating and a $534.25 consensus price target, implying upside. Key risks include execution on new product launches and competitive pressures, but solid fundamentals and raised guidance support a constructive view for investors seeking growth in biopharma.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Fiverr International Ltd
Fiverr International Ltd is involved in buying and selling digital services in the same fashion as physical goods on an e-commerce platform. It is set out to design a digital marketplace that is built with a comprehensive SKU-like services catalog and a search, finds, and order process that mirrors a typical e-commerce transaction. The service offerings of the company include Graphics and Design, Digital Marketing, Writing and Translation, and Video and Animation among others.
Read more on FVRR →About Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals is a global biotechnology company that discovers and develops small-molecule drugs for the treatment of serious diseases. Its key drugs are Kalydeco, Orkambi, Symdeko, and Trikafta/Kaftrio for cystic fibrosis, where Vertex therapies remain the standard of care globally. In addition to its focus on cystic fibrosis, Vertex is diversifying its pipeline through gene-editing therapies such as CTX001 for beta-thalassemia and sickle-cell disease, small-molecule inhibitors targeting acute and chronic pain using non-opioid treatments, and small-molecule inhibitors of APOL1-mediated kidney diseases. Vertex is also investigating cell therapies to deliver a potential functional cure for type 1 diabetes.
Read more on VRTX →
